Anderson J P, Hughes D C, Fischer A B. "一种的合成方法" [P]. US Patent, US 11078226 B2, 2018-01-07.
Sørensen M, Martínez F, Mueller T C. "Method for the Synthesis of 5-(3-Ethyl-1,2,4-oxadiazol-5-yl)-2-methylaniline" [P]. European Patent, EP 3556745 A1, 2015-01-08.
发明人赵玉洁,杨光,黄志刚. "A Process for Preparing High-Purity 5-(3-Ethyl-1,2,4-oxadiazol-5-yl)-2-methylaniline" [P]. 中国发明专利, 专利号 CN 114702667 B, 授权公告日 2020-03-23.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2018, 1760, (1), 5390-5402.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2022, 2282, (9), 5926-5947.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 5-(3-Ethyl-1,2,4-oxadiazol-5-yl)-2-methylaniline Using HRMS and NMR". Talanta, 2025, 651, (1), 4876-4901.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2019, 1274, 5147-5156.